BliNK Biomedical SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BliNK Biomedical SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10973
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BliNK Biomedical SAS (BliNK Biomedical) is a drug development company that discovers and develops antibody-based therapeutics for life threatening diseases such as cancer. The company’s lead pipeline program is a monoclonal antibody that targets novel immune-oncology and immune-checkpoint targets applicable for hematological and solid tumors. Its B cell technology enables to isolate specific antibody producing cells and is based on validated antibody discovery platforms such as IVV, ISAAC VIVA Screen technology that delivers antibody therapeutics for various targets. The company’s pipeline comprises three innovative targets for in-house development such as a novel GPCR drug target made drugable by BliNK’s technology. BliNK Biomedical is headquartered in Lyon, France.

BliNK Biomedical SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BliNK Biomedical SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BliNK Biomedical Raises Additional USD1.8 Million in Series A Financing 10
BliNK Biomedical Raises Funds through Series A Venture Financing 11
Partnerships 12
Valneva Forms Joint Venture with BliNK Therapeutics 12
Asset Transactions 13
Forty Seven Acquires Assets from BliNK Biomedical 13
BliNK Biomedical SAS – Key Competitors 14
BliNK Biomedical SAS – Key Employees 15
BliNK Biomedical SAS – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Key Facts 2
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BliNK Biomedical SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BliNK Biomedical SAS, Deals By Therapy Area, 2012 to YTD 2018 8
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BliNK Biomedical Raises Additional USD1.8 Million in Series A Financing 10
BliNK Biomedical Raises Funds through Series A Venture Financing 11
Valneva Forms Joint Venture with BliNK Therapeutics 12
Forty Seven Acquires Assets from BliNK Biomedical 13
BliNK Biomedical SAS, Key Competitors 14
BliNK Biomedical SAS, Key Employees 15
BliNK Biomedical SAS, Subsidiaries 16

List of Figures
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BliNK Biomedical SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BliNK Biomedical SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Colbun SA (COLBUN):電力:M&Aディール及び事業提携情報
    Summary Colbun SA (Colbun) is an electric utility that generates and transmits electricity. It produces electricity from various sources including hydro, diesel, natural gas, coal, wind and biomass. The company has operating and developing interests in various power plants. Colbun also procures elec …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • FOX Broadcasting Co:企業の戦略的SWOT分析
    FOX Broadcasting Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Strukton Groep Nv
    Strukton Groep Nv - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Warner Music Group Corp.:企業の戦略的SWOT分析
    Warner Music Group Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Diasome Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Diasome Pharmaceuticals Inc (Diasome) is a pharmaceutical company that focusses on clinical and commercial development of therapies for diabetes and obesity. The company offers products in the fields of cell receptor targeting, insulin replacement, and hepatic (liver) glucose metabolism. Its …
  • Godrej Consumer Products Limited:企業のM&A・事業提携・投資動向
    Godrej Consumer Products Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Godrej Consumer Products Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Nexter Group:企業の戦略・SWOT・財務情報
    Nexter Group - Strategy, SWOT and Corporate Finance Report Summary Nexter Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Aetna Inc:戦略・SWOT・企業財務分析
    Aetna Inc - Strategy, SWOT and Corporate Finance Report Summary Aetna Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a medical technology company that offers patient engagement and SaaS-based solutions. The company provides solutions including HIM, patient engagement, patient care, coding and CDI, and financial management solutions. It offers its patie …
  • Continuum Wind Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Continuum Wind Energy Ltd (Continuum Wind Energy), a subsidiary of Morgan Stanley Infrastructure Partners LP is a renewable energy company that constructs and develops wind farms and wind energy generation. The company's services include optimization of number of wind turbines to maximize ge …
  • Mahindra & Mahindra Limited:企業の戦略・SWOT・財務分析
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kimball Electronics Inc (KE):企業の財務・戦略的SWOT分析
    Kimball Electronics Inc (KE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lee Enterprises, Incorporated:企業の戦略・SWOT・財務情報
    Lee Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Lee Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Grenergy Renovables SL (GRE):電力:M&Aディール及び事業提携情報
    Summary Grenergy Renovables SL (Grenergy Renovables), a subsidiary of DARUAN Venture Capital SCR, is an alternative energy company that generates renewable energy through solar photovoltaic plants. The company provides services such as construction, engineering, and procurement services, project dev …
  • PositiveID Corp (PSID):企業の財務・戦略的SWOT分析
    Summary PositiveID Corp (PositiveID) formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products inc …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • EPAM Systems Inc (EPAM):企業の財務・戦略的SWOT分析
    EPAM Systems Inc (EPAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Procter & Gamble Hygiene and Health Care Ltd:企業の戦略・SWOT・財務分析
    Procter & Gamble Hygiene and Health Care Ltd - Strategy, SWOT and Corporate Finance Report Summary Procter & Gamble Hygiene and Health Care Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆